ArticleOncology letters2019

Radium-223 in patients with metastatic castration-resistant prostate cancer: Efficacy and safety in clinical practice.

Arsela Prelaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.